sales@fnfresearch.comTel: +86 21 80360450 | USA: +1-347-989-3985

Search Market Research Report

Home / Medical Device / Neuromodulation Devices

Neuromodulation Devices Market By Technology (Internal Neuromodulation (Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Spinal Cord Stimulation, and Others), and External Neuromodulation), By Application (Chronic Pain Management, Failed back syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinsons disease, Obsessive-Compulsive Disorder, Migraine), and By Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, and Ceramic Biomaterials): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

  • Publish On: Jun-2020
  • Total Pages: 162
  • Report Code: FAF-1213
  • Base Year: 2019
  • Format:

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the neuromodulation devices industry. The report analyzes and declares the historical and current trends analysis of the neuromodulation devices industry and subsequently recommends the projected trends anticipated to be observed in the neuromodulation devices market during the upcoming years.

The neuromodulation devices market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire neuromodulation devices market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of both volume (Units) and value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the neuromodulation devices industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the neuromodulation devices industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the neuromodulation devices market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the neuromodulation devices industry. The neuromodulation devices market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the Neuromodulation Devices sector. Key strategic developments in the neuromodulation devices market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the neuromodulation devices market are appropriately highlighted in the report.

The growth of the neuromodulation devices market is being fueled owing to the increasing incidence of chronic diseases, rising prevalence of neurological disorders and growing geriatric population. Moreover, ongoing research regarding such diseases has expanded market growth gradually. However, the high-cost involvement in neuromodulation procedures and components, coupled with the lack of trained professionals may curb the growth of the market over the analysis period. Furthermore, the expansion of the market in emerging countries will offer lucrative opportunities to the industry participants operating in neuromodulation devices market.

The neuromodulation devices market research report delivers an acute valuation and taxonomy of the neuromodulation devices industry by practically splitting the market on the basis of different types, applications, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the neuromodulation devices industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the neuromodulation devices industry is provided for the leading economies of the world.

The neuromodulation devices market is segmented based on technology, and application. On the basis of technology segmentation, the market is classified into internal neuromodulation, and external neuromodulation. The internal neuromodulation has been classified into vagus nerve stimulation (VNS), spinal cord stimulation (SCS), sacral nerve stimulation (SNS), deep brain stimulation (DBS), and Others. Moreover, the application segment in neuromodulation devices market is bifurcated into chronic pain, movement disorders, psychiatric conditions, gastroenterology & urology and other applications. Furthermore, the biomaterial segmentation has been classified into metallic biomaterials, polymeric biomaterials, and ceramic biomaterials.

Some of the essential players operating in the neuromodulation devices market, but not restricted to include Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova Plc, Nevro Corporation, Inspire Medical System Inc., Nuvectra, Neuropace Inc., Bioness Inc., Beijing PINS Medical Co., Ltd., Laborie Medical, and Neuronetics, Inc.

The taxonomy of the neuromodulation devices industry by its scope and segmentation is as follows:

Global Neuromodulation Devices Market: By Technology Segmentation Analysis

  • Internal Neuromodulation
    • Sacral Nerve Stimulation
    • Deep Brain Stimulation
    • Vagus Nerve Stimulation
    • Spinal Cord Stimulation
    • Others
  • External Neuromodulation

Global Neuromodulation Devices Market: By Application Segmentation Analysis

  • Chronic Pain Management
  • Failed back syndrome
  • Epilepsy
  • Tremor
  • Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinsons disease
  • Obsessive-Compulsive Disorder
  • Migraine

Global Neuromodulation Devices Market: By Biomaterial Segmentation Analysis

  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials

Global Neuromodulation Devices Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises a buoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Neuromodulation Devices market – Technology Analysis
    1. 2.1. Global Neuromodulation Devices Market – Technology Overview
    2. 2.2. Global Neuromodulation Devices Market Share, by Technology, 2018 & 2025 (USD Million)
    3. 2.3. Deep Brain Stimulation
      1. 2.3.1. Global Deep Brain Stimulation Neuromodulation Devices Market, 2016-2026 (USD Million)
    4. 2.4. Sacral Nerve Stimulation
      1. 2.4.1. Global Sacral Nerve Stimulation Neuromodulation Devices Market, 2016-2026 (USD Million)
    5. 2.5. Vagus Nerve Stimulation
      1. 2.5.1. Global Vagus Nerve Stimulation Neuromodulation Devices Market, 2016-2026 (USD Million)
    6. 2.6. Spinal Cord Stimulation
      1. 2.6.1. Global Spinal Cord Stimulation Neuromodulation Devices Market, 2016-2026 (USD Million)
  3. CHAPTER 3. Neuromodulation Devices market – Application Analysis
    1. 3.1. Global Neuromodulation Devices Market – Application Overview
    2. 3.2. Global Neuromodulation Devices Market Share, by Application, 2018 & 2025 (USD Million)
    3. 3.3. Chronic Pain Management
      1. 3.3.1. Global Chronic Pain Management Neuromodulation Devices Market, 2016-2026 (USD Million)
    4. 3.4. Failed back syndrome
      1. 3.4.1. Global Failed back syndrome Neuromodulation Devices Market, 2016-2026 (USD Million)
    5. 3.5. Epilepsy
      1. 3.5.1. Global Epilepsy Neuromodulation Devices Market, 2016-2026 (USD Million)
    6. 3.6. Tremor
      1. 3.6.1. Global Tremor Neuromodulation Devices Market, 2016-2026 (USD Million)
    7. 3.7. Incontinence
      1. 3.7.1. Global Incontinence Neuromodulation Devices Market, 2016-2026 (USD Million)
    8. 3.8. Depression
      1. 3.8.1. Global Depression Neuromodulation Devices Market, 2016-2026 (USD Million)
    9. 3.9. Dystonia
      1. 3.9.1. Global Dystonia Neuromodulation Devices Market, 2016-2026 (USD Million)
    10. 3.10. Gastroparesis
      1. 3.10.1. Global Gastroparesis Neuromodulation Devices Market, 2016-2026 (USD Million)
    11. 3.11. Parkinsons disease
      1. 3.11.1. Global Parkinsons disease Neuromodulation Devices Market, 2016-2026 (USD Million)
    12. 3.12. Obsessive-Compulsive Disorder
      1. 3.12.1. Global Obsessive-Compulsive Disorder Neuromodulation Devices Market, 2016-2026 (USD Million)
    13. 3.13. Migraine
      1. 3.13.1. Global Migraine Neuromodulation Devices Market, 2016-2026 (USD Million)
  4. CHAPTER 4. Neuromodulation Devices market – Biomaterial Analysis
    1. 4.1. Global Neuromodulation Devices Market – Biomaterial Overview
    2. 4.2. Global Neuromodulation Devices Market Share, by Biomaterial, 2018 & 2025 (USD Million)
    3. 4.3. Metallic
      1. 4.3.1. Global Metallic Neuromodulation Devices Market, 2016-2026 (USD Million)
    4. 4.4. Polymeric
      1. 4.4.1. Global Polymeric Neuromodulation Devices Market, 2016-2026 (USD Million)
    5. 4.5. Ceramic
      1. 4.5.1. Global Ceramic Neuromodulation Devices Market, 2016-2026 (USD Million)
  5. CHAPTER 5. Neuromodulation Devices market – Regional Analysis
    1. 5.1. Global Neuromodulation Devices Market Regional Overview
    2. 5.2. Global Neuromodulation Devices Market Share, by Region, 2018 & 2025 (Value)
    3. 5.3. North America
      1. 5.3.1. North America Neuromodulation Devices Market size and forecast, 2016-2026
      2. 5.3.2. North America Neuromodulation Devices Market, by Country, 2018 & 2025 (USD Million)
      3. 5.3.3. North America Neuromodulation Devices Market, by Technology, 2016-2026
        1. 5.3.3.1. North America Neuromodulation Devices Market, by Technology, 2016-2026 (USD Million)
      4. 5.3.4. North America Neuromodulation Devices Market, by Application, 2016-2026
        1. 5.3.4.1. North America Neuromodulation Devices Market, by Application, 2016-2026 (USD Million)
      5. 5.3.5. North America Neuromodulation Devices Market, by Biomaterial, 2016-2026
        1. 5.3.5.1. North America Neuromodulation Devices Market, by Biomaterial, 2016-2026 (USD Million)
      6. 5.3.6. U.S.
        1. 5.3.6.1. U.S. Market size and forecast, 2016-2026 (USD Million)
      7. 5.3.7. Canada
        1. 5.3.7.1. Canada Market size and forecast, 2016-2026 (USD Million)
    4. 5.4. Europe
      1. 5.4.1. Europe Neuromodulation Devices Market size and forecast, 2016-2026
      2. 5.4.2. Europe Neuromodulation Devices Market, by Country, 2018 & 2025 (USD Million)
      3. 5.4.3. Europe Neuromodulation Devices Market, by Technology, 2016-2026
        1. 5.4.3.1. Europe Neuromodulation Devices Market, by Technology, 2016-2026 (USD Million)
      4. 5.4.4. Europe Neuromodulation Devices Market, by Application, 2016-2026
        1. 5.4.4.1. Europe Neuromodulation Devices Market, by Application, 2016-2026 (USD Million)
      5. 5.4.5. Europe Neuromodulation Devices Market, by Biomaterial, 2016-2026
        1. 5.4.5.1. Europe Neuromodulation Devices Market, by Biomaterial, 2016-2026 (USD Million)
      6. 5.4.6. Germany
        1. 5.4.6.1. Germany Market size and forecast, 2016-2026 (USD Million)
      7. 5.4.7. France
        1. 5.4.7.1. France Market size and forecast, 2016-2026 (USD Million)
      8. 5.4.8. U.K.
        1. 5.4.8.1. U.K. Market size and forecast, 2016-2026 (USD Million)
      9. 5.4.9. Italy
        1. 5.4.9.1. Italy Market size and forecast, 2016-2026 (USD Million)
      10. 5.4.10. Spain
        1. 5.4.10.1. Spain Market size and forecast, 2016-2026 (USD Million)
      11. 5.4.11. Rest of Europe
        1. 5.4.11.1. Rest of Europe Market size and forecast, 2016-2026 (USD Million)
    5. 5.5. Asia Pacific
      1. 5.5.1. Asia Pacific Neuromodulation Devices Market size and forecast, 2016-2026
      2. 5.5.2. Asia Pacific Neuromodulation Devices Market, by Country, 2018 & 2025 (USD Million)
      3. 5.5.3. Asia Pacific Neuromodulation Devices Market, by Technology, 2016-2026
        1. 5.5.3.1. Asia Pacific Neuromodulation Devices Market, by Technology, 2016-2026 (USD Million)
      4. 5.5.4. Asia Pacific Neuromodulation Devices Market, by Application, 2016-2026
        1. 5.5.4.1. Asia Pacific Neuromodulation Devices Market, by Application, 2016-2026 (USD Million)
      5. 5.5.5. Asia Pacific Neuromodulation Devices Market, by Biomaterial, 2016-2026
        1. 5.5.5.1. Asia Pacific Neuromodulation Devices Market, by Biomaterial, 2016-2026 (USD Million)
      6. 5.5.6. China
        1. 5.5.6.1. China Market size and forecast, 2016-2026 (USD Million)
      7. 5.5.7. Japan
        1. 5.5.7.1. Japan Market size and forecast, 2016-2026 (USD Million)
      8. 5.5.8. India
        1. 5.5.8.1. India Market size and forecast, 2016-2026 (USD Million)
      9. 5.5.9. South Korea
        1. 5.5.9.1. South Korea Market size and forecast, 2016-2026 (USD Million)
      10. 5.5.10. South-East Asia
        1. 5.5.10.1. South-East Asia Market size and forecast, 2016-2026 (USD Million)
      11. 5.5.11. Rest of Asia Pacific
        1. 5.5.11.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Million)
    6. 5.6. Latin America
      1. 5.6.1. Latin America Neuromodulation Devices Market size and forecast, 2016-2026
      2. 5.6.2. Latin America Neuromodulation Devices Market, by Country, 2018 & 2025 (USD Million)
      3. 5.6.3. Latin America Neuromodulation Devices Market, by Technology, 2016-2026
        1. 5.6.3.1. Latin America Neuromodulation Devices Market, by Technology, 2016-2026 (USD Million)
      4. 5.6.4. Latin America Neuromodulation Devices Market, by Application, 2016-2026
        1. 5.6.4.1. Latin America Neuromodulation Devices Market, by Application, 2016-2026 (USD Million)
      5. 5.6.5. Latin America Neuromodulation Devices Market, by Biomaterial, 2016-2026
        1. 5.6.5.1. Latin America Neuromodulation Devices Market, by Biomaterial, 2016-2026 (USD Million)
      6. 5.6.6. Brazil
        1. 5.6.6.1. Brazil Market size and forecast, 2016-2026 (USD Million)
      7. 5.6.7. Mexico
        1. 5.6.7.1. Mexico Market size and forecast, 2016-2026 (USD Million)
      8. 5.6.8. Rest of Latin America
        1. 5.6.8.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Million)
    7. 5.7. The Middle-East and Africa
      1. 5.7.1. The Middle-East and Africa Neuromodulation Devices Market size and forecast, 2016-2026
      2. 5.7.2. The Middle-East and Africa Neuromodulation Devices Market, by Country, 2018 & 2025 (USD Million)
      3. 5.7.3. The Middle-East and Africa Neuromodulation Devices Market, by Technology, 2016-2026
        1. 5.7.3.1. The Middle-East and Africa Neuromodulation Devices Market, by Technology, 2016-2026 (USD Million)
      4. 5.7.4. The Middle-East and Africa Neuromodulation Devices Market, by Application, 2016-2026
        1. 5.7.4.1. The Middle-East and Africa Neuromodulation Devices Market, by Application, 2016-2026 (USD Million)
      5. 5.7.5. The Middle-East and Africa Neuromodulation Devices Market, by Biomaterial, 2016-2026
        1. 5.7.5.1. The Middle-East and Africa Neuromodulation Devices Market, by Biomaterial, 2016-2026 (USD Million)
      6. 5.7.6. GCC Countries
        1. 5.7.6.1. GCC Countries Market size and forecast, 2016-2026 (USD Million)
      7. 5.7.7. South Africa
        1. 5.7.7.1. South Africa Market size and forecast, 2016-2026 (USD Million)
      8. 5.7.8. Rest of Middle-East Africa
        1. 5.7.8.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million)
  6. CHAPTER 6. Neuromodulation Devices market – Competitive Landscape
    1. 6.1. Competitor Market Share – Revenue
    2. 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 6.3. Strategic Development
      1. 6.3.1. Acquisitions and Mergers
      2. 6.3.2. New Products
      3. 6.3.3. Research & Development Activities
  7. CHAPTER 7. Company Profiles
    1. 7.1. Medtronic plc
      1. 7.1.1. Company Overview
      2. 7.1.2. Medtronic plc Revenue and Gross Margin
      3. 7.1.3. Product portfolio
      4. 7.1.4. Recent initiatives
    2. 7.2. St. Jude Medical, Inc.
      1. 7.2.1. Company Overview
      2. 7.2.2. St. Jude Medical, Inc. Revenue and Gross Margin
      3. 7.2.3. Product portfolio
      4. 7.2.4. Recent initiatives
    3. 7.3. LivaNova PLC
      1. 7.3.1. Company Overview
      2. 7.3.2. LivaNova PLC Revenue and Gross Margin
      3. 7.3.3. Product portfolio
      4. 7.3.4. Recent initiatives
    4. 7.4. Boston Scientific Corporation
      1. 7.4.1. Company Overview
      2. 7.4.2. Boston Scientific Corporation Revenue and Gross Margin
      3. 7.4.3. Product portfolio
      4. 7.4.4. Recent initiatives
    5. 7.5. Aleva Neurotherapeutics SA
      1. 7.5.1. Company Overview
      2. 7.5.2. Aleva Neurotherapeutics SA Revenue and Gross Margin
      3. 7.5.3. Product portfolio
      4. 7.5.4. Recent initiatives
    6. 7.6. BioControl Medical
      1. 7.6.1. Company Overview
      2. 7.6.2. BioControl Medical Revenue and Gross Margin
      3. 7.6.3. Product portfolio
      4. 7.6.4. Recent initiatives
    7. 7.7. Bioness Inc.
      1. 7.7.1. Company Overview
      2. 7.7.2. Bioness Inc. Revenue and Gross Margin
      3. 7.7.3. Product portfolio
      4. 7.7.4. Recent initiatives
    8. 7.8. EnteroMedics Inc
      1. 7.8.1. Company Overview
      2. 7.8.2. EnteroMedics Inc Revenue and Gross Margin
      3. 7.8.3. Product portfolio
      4. 7.8.4. Recent initiatives
    9. 7.9. Nevro Corporation
      1. 7.9.1. Company Overview
      2. 7.9.2. Nevro Corporation Revenue and Gross Margin
      3. 7.9.3. Product portfolio
      4. 7.9.4. Recent initiatives
    10. 7.10. NeuroPace Inc.
      1. 7.10.1. Company Overview
      2. 7.10.2. NeuroPace Inc. Revenue and Gross Margin
      3. 7.10.3. Product portfolio
      4. 7.10.4. Recent initiatives
  8. CHAPTER 8. Neuromodulation Devices — Industry Analysis
    1. 8.1. Neuromodulation Devices Market – Key Trends
      1. 8.1.1. Market Drivers
      2. 8.1.2. Market Restraints
      3. 8.1.3. Market Opportunities
    2. 8.2. Value Chain Analysis
    3. 8.3. Technology Roadmap and Timeline
    4. 8.4. Neuromodulation Devices Market – Attractiveness Analysis
      1. 8.4.1. By Technology
      2. 8.4.2. By Application
      3. 8.4.3. By Biomaterial
      4. 8.4.4. By Region
  9. CHAPTER 9. Marketing Strategy Analysis, Distributors
    1. 9.1. Marketing Channel
    2. 9.2. Direct Marketing
    3. 9.3. Indirect Marketing
    4. 9.4. Marketing Channel Development Trend
    5. 9.5. Economic/Political Environmental Change
  10. CHAPTER 10. Report Conclusion
  11. CHAPTER 11. Research Approach & Methodology
    1. 11.1. Report Description
    2. 11.2. Research Scope
    3. 11.3. Research Methodology
      1. 11.3.1. Secondary Research
      2. 11.3.2. Primary Research
      3. 11.3.3. Models
        1. 11.3.3.1. Company Share Analysis Model
        2. 11.3.3.2. Revenue Based Modeling
        3. 11.3.3.3. Research Limitations

        List of Figures

        FIG. 1 Global Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 2 Global Neuromodulation Devices Market Share, by Technology, 2018 & 2025 (USD Million)
        FIG. 3 Global Deep Brain Stimulation Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 4 Global Sacral Nerve Stimulation Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 5 Global Vagus Nerve Stimulation Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 6 Global Spinal Cord Stimulation Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 7 Global Neuromodulation Devices Market Share, by Application, 2018 & 2025 (USD Million)
        FIG. 8 Global Chronic Pain Management Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 9 Global Failed back syndrome Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 10 Global Epilepsy Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 11 Global Tremor Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 12 Global Incontinence Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 13 Global Depression Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 14 Global Dystonia Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 15 Global Gastroparesis Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 16 Global Parkinsons disease Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 17 Global Obsessive-Compulsive Disorder Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 18 Global Migraine Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 19 Global Neuromodulation Devices Market Share, by Biomaterial, 2018 & 2025 (USD Million)
        FIG. 20 Global Metallic Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 21 Global Polymeric Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 22 Global Ceramic Neuromodulation Devices Market, 2016-2026 (USD Million)
        FIG. 23 Global Neuromodulation Devices Market Share, by Region, 2018 & 2025
        FIG. 24 North America Neuromodulation Devices Market, 2016-2026
        FIG. 25 U.S. Neuromodulation Devices Market, 2016-2026
        FIG. 26 Canada Neuromodulation Devices Market, 2016-2026
        FIG. 27 Europe Neuromodulation Devices Market, 2016-2026
        FIG. 28 Germany Neuromodulation Devices Market, 2016-2026
        FIG. 29 France Neuromodulation Devices Market, 2016-2026
        FIG. 30 U.K. Neuromodulation Devices Market, 2016-2026
        FIG. 31 Italy Neuromodulation Devices Market, 2016-2026
        FIG. 32 Spain Neuromodulation Devices Market, 2016-2026
        FIG. 33 Rest of Europe Neuromodulation Devices Market, 2016-2026
        FIG. 34 Asia Pacific Neuromodulation Devices Market, 2016-2026
        FIG. 35 China Neuromodulation Devices Market, 2016-2026
        FIG. 36 Japan Neuromodulation Devices Market, 2016-2026
        FIG. 37 India Neuromodulation Devices Market, 2016-2026
        FIG. 38 South  Korea Neuromodulation Devices Market, 2016-2026
        FIG. 39 South-East Asia Neuromodulation Devices Market, 2016-2026
        FIG. 40 Rest of Asia Pacific Neuromodulation Devices Market, 2016-2026
        FIG. 41 Latin America Neuromodulation Devices Market, 2016-2026
        FIG. 42 Brazil Neuromodulation Devices Market, 2016-2026
        FIG. 43 Mexico Neuromodulation Devices Market, 2016-2026
        FIG. 44 Rest of Latin America Neuromodulation Devices Market, 2016-2026
        FIG. 45 The Middle-East and Africa Neuromodulation Devices Market, 2016-2026
        FIG. 46 GCC Countries Neuromodulation Devices Market, 2016-2026
        FIG. 47 South Africa Neuromodulation Devices Market, 2016-2026
        FIG. 48 Rest of Middle-East Africa Neuromodulation Devices Market, 2016-2026
        FIG. 49 Competitor Market Share – Revenue
        FIG. 50 Medtronic plc Revenue and Growth Rate
        FIG. 51 Medtronic plc Market Share
        FIG. 52 St. Jude Medical, Inc. Revenue and Growth Rate
        FIG. 53 St. Jude Medical, Inc. Market Share
        FIG. 54 LivaNova PLC Revenue and Growth Rate
        FIG. 55 LivaNova PLC Market Share
        FIG. 56 Boston Scientific Corporation Revenue and Growth Rate
        FIG. 57 Boston Scientific Corporation Market Share
        FIG. 58 Aleva Neurotherapeutics SA Revenue and Growth Rate
        FIG. 59 Aleva Neurotherapeutics SA Market Share
        FIG. 60 BioControl Medical Revenue and Growth Rate
        FIG. 61 BioControl Medical Market Share
        FIG. 62 Bioness Inc. Revenue and Growth Rate
        FIG. 63 Bioness Inc. Market Share
        FIG. 64 EnteroMedics Inc Revenue and Growth Rate
        FIG. 65 EnteroMedics Inc Market Share
        FIG. 66 Nevro Corporation Revenue and Growth Rate
        FIG. 67 Nevro Corporation Market Share
        FIG. 68 NeuroPace Inc. Revenue and Growth Rate
        FIG. 69 NeuroPace Inc. Market Share
        FIG. 70 Market Dynamics
        FIG. 71 Global Neuromodulation Devices – Value Chain Analysis
        FIG. 72 Technology Roadmap and Timeline
        FIG. 73 Market Attractiveness Analysis – By Technology
        FIG. 74 Market Attractiveness Analysis – By Application
        FIG. 75 Market Attractiveness Analysis – By Biomaterial
        FIG. 76 Market Attractiveness Analysis – By Region
        FIG. 77 Market Channel
        FIG. 78 Marketing Channel Development Trend
        FIG. 79 Growth in World Gross Product, 2008-2018

        List of Tables

        TABLE 1 Global Neuromodulation Devices Market, 2018 & 2025 (USD Million)
        TABLE 2 Global Neuromodulation Devices market, by Technology, 2016-2026 (USD Million)
        TABLE 3 Global Neuromodulation Devices market, by Application, 2016-2026 (USD Million)
        TABLE 4 Global Neuromodulation Devices market, by Biomaterial, 2016-2026 (USD Million)
        TABLE 5 Global Neuromodulation Devices market, by Region, 2016-2026 (USD Million)
        TABLE 6 North America Neuromodulation Devices Market, by Technology, 2016-2026 (USD Million)
        TABLE 7 North America Neuromodulation Devices Market, by Application, 2016-2026 (USD Million)
        TABLE 8 North America Neuromodulation Devices Market, by Biomaterial, 2016-2026 (USD Million)
        TABLE 9 Europe Neuromodulation Devices Market, by Technology, 2016-2026 (USD Million)
        TABLE 10 Europe Neuromodulation Devices Market, by Application, 2016-2026 (USD Million)
        TABLE 11 Europe Neuromodulation Devices Market, by Biomaterial, 2016-2026 (USD Million)
        TABLE 12 Asia Pacific Neuromodulation Devices Market, by Technology, 2016-2026 (USD Million)
        TABLE 13 Asia Pacific Neuromodulation Devices Market, by Application, 2016-2026 (USD Million)
        TABLE 14 Asia Pacific Neuromodulation Devices Market, by Biomaterial, 2016-2026 (USD Million)
        TABLE 15 Latin America Neuromodulation Devices Market, by Technology, 2016-2026 (USD Million)
        TABLE 16 Latin America Neuromodulation Devices Market, by Application, 2016-2026 (USD Million)
        TABLE 17 Latin America Neuromodulation Devices Market, by Biomaterial, 2016-2026 (USD Million)
        TABLE 18 The Middle-East and Africa Neuromodulation Devices Market, by Technology, 2016-2026 (USD Million)
        TABLE 19 The Middle-East and Africa Neuromodulation Devices Market, by Application, 2016-2026 (USD Million)
        TABLE 20 The Middle-East and Africa Neuromodulation Devices Market, by Biomaterial, 2016-2026 (USD Million)
        TABLE 21 Global Neuromodulation Devices Market - Company Revenue Analysis 2016-2019 (USD Million)
        TABLE 22 Global Neuromodulation Devices Market - Company Revenue Share Analysis 2016-2019(%)
        TABLE 23 Acquisitions and Mergers
        TABLE 24 New Product/Service Launch
        TABLE 25 Research & Development Activities
        TABLE 26 Market Drivers
        TABLE 27 Market Restraints
        TABLE 28 Market Opportunities

Key Insights from Primary Research

  • According to the primary CXO’s of the global neuromodulation devices market, the market is estimated to witness a substantial growth of nearly 9.5% over the forecast period.
  • The market was valued at USD 4 billion, in 2019 and is expected to be valued over USD 9 billion.
  • By product type segmentation analysis, the spinal cord stimulator headed the market in 2019 and it is expected to grow over the forecast period attributed to rising chronic back pain and increasing focus towards the neuromodulation techniques by healthcare provider.
  • On the basis of type segmentation analysis, the invasive category dominated the market in 2019.
  • By geography, in 2019, North America dominated the market due to the high adoption of neuromodulation devices for chronic conditions treatment.

Key Recommendations from Analysts

  • Our analysts recommend that the Asia Pacific region will dominate the global market for the neuromodulation devices owing to growing awareness about healthcare, increasing per capita income and healthcare expenditure.  
  • The Europe is anticipated to boost market for the neuromodulation devices owing to increasing number of regional players and improving diagnostics treatments,
  • Due to the increasing increasing prevalence of chronic back pain, the pain management category is projected to boost the market.
  • The hospital category is expected to boost the market owing to the growing number of patients suffering from chronicle diseases.
  • Owing to the increasing demand for the neuromodulation devices, and new inventions in the neuromodulation technology may create numerous opportunities in the market over the forecast period.

Market Attractiveness by Regional Analysis

Industry Major Market Players

  • Medtronic Plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova Plc
  • Nevro Corporation
  • Inspire Medical System Inc.
  • Nuvectra
  • Neuropace Inc.
  • Bioness Inc.
  • Beijing PINS Medical Co. Ltd.
  • Laborie Medical
  • Neuronetics Inc.

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions